Cristina Saura, MD, on Choosing Neoadjuvant Treatment for Patients With Early Breast Cancer

Posted: Tuesday, November 14, 2017

In your community, practice, or institution, does the surgeon identify appropriate candidates for a neoadjuvant regimen, which could include pertuzumab, and refer them to the breast oncologist?